Maxxsartim 150 (Irbesartan)

Maxxsartim 150 is a pharmaceutical product containing Irbesartan, an angiotensin II receptor antagonist used primarily for the treatment of hypertension (high blood pressure). The product shown is manufactured by Ampharco U.S.A PJSC, a prominent pharmaceutical company based in Vietnam. Despite the 'U.S.A' in its name, which reflects a historical collaboration and technology transfer, the production facilities are located in the Nhon Trach III Industrial Park in Dong Nai Province, Vietnam.

Ampharco U.S.A was established as a joint venture and has since grown into a Public Joint Stock Company (PJSC). It operates modern manufacturing plants that adhere to international standards such as WHO-GMP. The brand is locally managed and owned within Vietnam, serving both the domestic market and export markets in the Southeast Asian region. The packaging in the image also features a prescription label from a Cambodian healthcare facility, indicating its distribution and use within the ASEAN region.